Evaluating efgartigimod dosing patterns among Canadian patients with generalized myasthenia gravis: real-world evidence from a patient support program

Vyvgart (efgartigimod alfa-fcab) - argenx, Broteio

https://event.fourwaves.com/cnsf2026/abstracts/16109e69-0a2e-454d-b8d7-a06c257e556a

Grayson Beecher; Carolina Barnett-Tapia; Richard Leckey; Cecilia Vu; Zaeem Siddiqi; Mihir Dhingra; Cécile Blein; Vera Bril; Oliver Blanchard; Michelle Mezei; Dubravka Dodig; Bupe Mwaikambo

Jul 21, 2026